Racial disparities in utilization of first line targeted therapies for metastatic breast cancer

被引：0
|
作者：
Martei, Yehoda M.
Chen, Kan
Mamtani, Ronac
Shulman, Lawrence N.
Hubbard, Rebecca A.
Clark, Amy Sanders
机构：
[1] Univ Penn, Dept Med, Hematol Oncol Div, Philadelphia, PA USA
[2] Univ Penn, Philadelphia, PA USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6528
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Racial disparities in utilization and effectiveness of first-line therapies in metastatic castrate-resistant prostate cancer.
    Marar, Mallika
    Mamtani, Ronac
    Narayan, Vivek
    Vapiwala, Neha
    Parikh, Ravi Bharat
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] An update on first line therapies for metastatic breast cancer
    Fedele, Palma
    Ciccarese, Mariangela
    Surico, Giammarco
    Cinieri, Saverio
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (03) : 243 - 252
  • [3] First line targeted therapies in breast cancer: focus on bevacizumab
    Milano, Amalia
    Nasti, Gugliemo
    Iaffaioli, Rosario Vincenzo
    Caponigro, Francesco
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (01): : 3 - 10
  • [4] Novel targeted therapies for metastatic breast cancer
    Jazieh, Khalid
    Bell, Ruth
    Agarwal, Nayan
    Abraham, Jame
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (14)
  • [5] Racial and regional disparities in metastatic breast cancer.
    Singhal, Sachi
    Desai, Devashish
    Khosla, Akshita
    Lanade, Oladimeji
    Potdar, Rashmika
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab
    Tonini, Giuseppe
    Calvieri, Alice
    Vincenzi, Bruno
    Santini, Daniele
    ONCOTARGETS AND THERAPY, 2009, 2 : 73 - 82
  • [7] Surrogate endpoints in metastatic breast cancer treated with targeted therapies: an analysis of the first-line phase III trials
    Fausto Petrelli
    Sandro Barni
    Medical Oncology, 2014, 31
  • [8] Surrogate endpoints in metastatic breast cancer treated with targeted therapies: an analysis of the first-line phase III trials
    Petrelli, Fausto
    Barni, Sandro
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [9] Docetaxel combined with targeted therapies in metastatic breast cancer
    Cortes, Javier
    Roche, Henri
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 387 - 396
  • [10] Current and emerging targeted therapies for metastatic breast cancer
    Perez, Edith A.
    Spano, Jean-Philippe
    CANCER, 2012, 118 (12) : 3014 - 3025
12345